HOXA13 and non-small cell lung carcinoma: HOXA13 expression increased β-catenin, and its downstream MYC, CCND1, and matrix metalloproteinase 7 (MMP7) have been shown to promote EMT, metastasis, and poor patient prognosis in NSCLC [173,174].